3) CIVBP The Control Institute of Veterinary Bioproducts and Pharmaceuticals (China)
兽医药品监察所[中]
4) medical products
医药产品
1.
Based on the statistical analysis on the CGMP Warning Letters of medical products issued by FDA,FD'Asadministrative emphasis and intent on quality management system of medical products are presumed in order toimprove the level of quality management of medical businesses in China.
统计分析FDA发布的医药产品CGMP相关警告信,推测FDA对医药产品质量管理体系监管的重点和意图,为我国医药企业提高质量管理水平提供借鉴。
2.
It has been a long time that the low value-added material medicine composed the main Chinese medical products exports,and Chinese herbs occupied only a small share in international market.
我国医药产品的出口长期未能摆脱以附加价值低的原料药为主、中药产品国际市场份额小、成药产品无法出口的格局,其主要原因是由于发达国家在药品进口上设置的多重技术性贸易壁垒成为我国医药产品无法逾越的篱墙。
5) pharmaceutical product
医药产品
1.
OBJECTIVE:To provide information about the brand positioning of pharmaceutical products for reference of Chinese pharmaceutical business.
方法 :简述医药产品品牌定位的涵义及其基础 ,提出医药产品品牌定位的策略。
6) hospital medicine
医疗药品
1.
As a special product, hospital medicine has formed a particular supply chain during the process from produc-tion and patient consumption.
医疗药品作为一种特殊产品,从生产到应用于病人身上的过程中,形成了一个特殊的供应链。
补充资料：复兴中医
复兴中医
中医药期刊。时逸人主编。月刊。发行地上海。1940年1月创刊，1941年11月停刊。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条